We also demonstrated that miR-144-5p and miR-451a inhibited the progression of cholangiocarcinoma through targeting ST8SIA4 (Figure 6; Supplementary Figure S4). This evidence concerns the gene ST8SIA4 and cholangiocarcinoma.